The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...

The letter goes on to say that it is "inevitable" that the release of more discovery in the case will further violate their privacy, expose them to threats and create "a climate of possible ...